Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: A retrospective analysis

Journal of B.U.ON.

Volumn 18, Issue 1, 2013, Pages 105-115

  Diamantis, Nikolaos ^a   Xynos, I D ^b   Amptulah, S ^a   Karadima, M ^a   Skopelitis, H ^c   Tsavaris, N ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c GENERAL HOSPITAL OF NIKEA   (Greece)

Author keywords

Colorectal cancer; Disease free survival; Prognostic factors; Recurrence rate; Smoking

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; COLORECTAL CANCER; COMORBIDITY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SMOKING;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COLECTOMY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84879010871     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm 2007;13(6 Suppl C):S5-18.
2. Horner MJ RL, Krapcho M, Neyman N et al. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/ 1975-2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009.
3. Weitz J, Koch M, Debus J et al. Colorectal cancer. Lancet 2005;365(9454):153-165. (Pubitemid 40091806)
4. Compton CC, Fielding LP, Burgart LJ et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979-994. (Pubitemid 30602039)
5. Coleman M, Babb P, Damiecki P. Cancer Survival Trends in England and Wales, 1971-1995: Deprivation and NHS Region. Vol. 1999: TSO.
6. Rachet B, Maringe C, Nur U et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009;10:351-369.
7. Richard M. Trends and inequalities in survival for 20 cancers in England and Wales 1986-2001: population-based analyses and clinical commentaries. Foreword. Br J Cancer 2008;99 (Suppl 1):4-10.
8. Gill S, Loprinzi CL, Sargent DJ et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 2004;22:1797-1806. (Pubitemid 41095169)
9. Marsoni S. Efficacy of adjuvant fluorouracil and leucovorin in stage B and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Semin Oncol 2001;28(1 Suppl 1):14-19.
10. Newcomb PA, Storer BE, Marcus PM. Cigarette smoking in relation to risk of large bowel cancer in women. Cancer Res 1995;55:4906-4909.
11. Mizoue T, Inoue M, Tanaka K et al. Tobacco smoking and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2006;36:25-39. (Pubitemid 43210732)
12. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 2009;124:2406-2415.
13. Gospodarowicz M, Mackillop W, O'Sullivan B et al. Prognostic factors in clinical decision making: the future. Cancer 2001;91(8Suppl):1688-1695. (Pubitemid 32319247)
14. Sorbye H, Kohne CH, Sargent DJ, Glimelius B. Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification. Ann Oncol 2007;18:1666-1672. (Pubitemid 47506253)
15. Siu LL, Tannock IF. Handbook of Statistics in Clinical Oncology. New York NMDI, 2001;pp 473-490.
16. Ravdin PM, Siminoff IA, Harvey JA. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 1998;16:515-521. (Pubitemid 28135593)
17. Loprinzi CL, Ravdin PM, de Laurentiis M et al. Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? J Clin Oncol 1994;12:1422-1426. (Pubitemid 24206241)
18. Burrows J, Lammersfeld C, Dahlk S et al. Gupta Impact of self-reported performance status on survival in advanced colorectal cancer. J Clin Oncol, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
19. Yuste AL, Aparicio J, Segura A et al. Analysis of clinical prognostic factors for survival and time to progression in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapy. Clin Colorectal Cancer 2003;2:231-234. (Pubitemid 36367309)
20. Sargent DJ, Kohne CH, Sanoff HK et al. Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer. J Clin Oncol 2009;27:1948-1955.
21. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-1425. (Pubitemid 39429665)
22. Ju JH, Chang SC, Wang HS et al. Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis 2007;22:855-862.
23. Wang WS, Lin JK, Chiou TJ et al. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroenterology 2002;49:160-164.
24. Reiter W, Stieber P, Reuter C et al. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res 2000;20:5195-5198. (Pubitemid 32319106)
25. Sato H MK, Sugihara K, Mochizuki H et al. High-risk stage II colon cancer after curative resection. J Surg Oncol 2011;104:45-52.
26. El-Awady S, Lithy R, Morshed M et al. Utility of serum pre-operative carcinoemberyonic antigen in colorectal cancer patients. Hepatogastroenterology 2009;56:361-366.
27. Shitara K, Matsuo K, Takahari D et al. Neutropenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX. Eur J Cancer 2009;45:1757-1763.
28. Buc E, Kwiatkowski F, Alves A et al. Tobacco smoking: a factor of early onset of colorectal cancer. Dis Colon Rectum 2006;49:1893-1896. (Pubitemid 44853447)
29. Munro AJ, Bentley AH, Ackland C et al. Smoking compromises cause-specific survival in patients with operable colorectal cancer. Clin Oncol (R Coll Radiol) 2006;18:436-440. (Pubitemid 43942238)
30. McCleary NJ, Niedzwiecki D, Hollis D et al. Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803. Cancer 2011;116:957-966.
31. Meliska CJ, Stunkard ME, Gilbert DG et al. Immune function in cigarette smokers who quit smoking for 31 days. J Allergy Clin Immunol 1995;95:901-910.
32. O'Byrne KJ, Dalgleish AG, Browning MJ et al. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 2000;36:151-169. (Pubitemid 30102191)
33. Cairns RA, Hill RP. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 2004;64:2054-2061. (Pubitemid 38339453)
34. Ye YN, Wu WK, Shin VY et al. A mechanistic study of colon cancer growth promoted by cigarette smoke extract. Eur J Pharmacol 2005;519:52-57. (Pubitemid 43181164)
35. Faber MS, Jetter A, Fuhr U. Assessment of CYP1 A2 activity in clinical practice: why, how, and when? Basic Clin Pharmacol Toxicol 2005;97:125-134.
36. Diergaarde B VA, van Kraats AA, van Muijen GN et al. Cigarette smoking and genetic alterations in sporadic colon carcinomas. Carcinogenesis 2003;24:565-571.
37. Limsui VR, Vierkant RA, Smyrk TC et al. Cigarette smoking and subtype-specific colorectal cancer risks among older women. 2009 Gastrointestinal Cancers Symposium Proceedings, 2009, abstr 286.
38. Slattery ML, Curtin K, Anderson K et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000;92:1831-1836.